Corrigendum

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

J. A. Kulas, W. F. Franklin, N. A. Smith, G. D. Manocha, K. L. Puig, K. Nagamoto-Combs, R. D. Hendrix, Giulio Taglialatela, S. W. Barger, C. K. Combs

Research output: Contribution to journalComment/debate

Abstract

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

Original languageEnglish (US)
Pages (from-to)E345
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume316
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

Fingerprint

Insulysin
Amyloid beta-Protein Precursor
Brain
corrigendum

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

Corrigendum : Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018). / Kulas, J. A.; Franklin, W. F.; Smith, N. A.; Manocha, G. D.; Puig, K. L.; Nagamoto-Combs, K.; Hendrix, R. D.; Taglialatela, Giulio; Barger, S. W.; Combs, C. K.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 316, No. 2, 01.02.2019, p. E345.

Research output: Contribution to journalComment/debate

@article{4d8ab7f4c1ec44239b98da414e47dfd5,
title = "Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)",
abstract = "Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”",
author = "Kulas, {J. A.} and Franklin, {W. F.} and Smith, {N. A.} and Manocha, {G. D.} and Puig, {K. L.} and K. Nagamoto-Combs and Hendrix, {R. D.} and Giulio Taglialatela and Barger, {S. W.} and Combs, {C. K.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1152/ajpendo.zh1-8043-corr.2019",
language = "English (US)",
volume = "316",
pages = "E345",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Corrigendum

T2 - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

AU - Kulas, J. A.

AU - Franklin, W. F.

AU - Smith, N. A.

AU - Manocha, G. D.

AU - Puig, K. L.

AU - Nagamoto-Combs, K.

AU - Hendrix, R. D.

AU - Taglialatela, Giulio

AU - Barger, S. W.

AU - Combs, C. K.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

AB - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

UR - http://www.scopus.com/inward/record.url?scp=85061150736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061150736&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.zh1-8043-corr.2019

DO - 10.1152/ajpendo.zh1-8043-corr.2019

M3 - Comment/debate

VL - 316

SP - E345

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 2

ER -